Innovative Eyewear Inc current report, Q2 FY2024

Business Context and Reporting Period

Company: Innovative Eyewear, Inc. (Ticker: LUCY)
Filing Type: Form 8-K (Current Report)
Date of Report: May 28, 2024
Event: Entry into a Material Definitive Agreement for a registered direct offering and concurrent private placement.

Key Financial Metrics and Transaction Details

  • Gross Proceeds: Approximately $2.5 million.
  • Net Proceeds: Approximately $2.1 million (after fees and expenses).
  • Securities Issued:
    • 5,263,161 shares of Common Stock.
    • Warrants to purchase up to 5,263,161 shares of Common Stock (Purchase Warrants).
    • Placement Agent Warrants to purchase up to 394,737 shares of Common Stock.
  • Pricing: Combined purchase price of $0.475 per Share and Purchase Warrant.
  • Warrant Terms: Purchase Warrants are immediately exercisable, expire in five years, and have an exercise price of $0.475 per share. Placement Agent Warrants have an exercise price of $0.5938 per share.
  • Use of Proceeds: General corporate purposes and working capital.

Material Changes and Transaction Structure

The Company entered into a Securities Purchase Agreement with institutional investors to raise capital. This transaction represents a significant capital event distinct from prior periods, involving a registered direct offering of common stock and a concurrent private placement of warrants. The closing is expected on or about May 29, 2024.

Placement Agent Compensation (H.C. Wainwright & Co., LLC):

  • Cash fee: 6.0% of gross proceeds.
  • Management fee: 1.0% of gross proceeds.
  • Non-accountable expense: $50,000.
  • Clearing expenses: $15,950.
  • Warrants to purchase up to 394,737 shares.

Guidance, Outlook, and Risks

Management Commentary: The Company intends to utilize the net proceeds for general corporate purposes and working capital. The Company has agreed to file a registration statement for the resale of Warrant Shares within 5 calendar days and use commercially reasonable efforts to have it declared effective within 30 days (or 60 days in the event of a full review).

Risks and Contingencies:

  • Closing Conditions: The transaction is subject to the satisfaction of customary closing conditions.
  • Registration Timing: The ability to resell warrant shares depends on the SEC declaring the registration statement effective within the specified timelines.
  • Dilution: The issuance of new shares and warrants will result in dilution to existing shareholders.

Note: This filing does not provide specific revenue, profit, cash flow, margin, or debt metrics for the reporting period.

Investor Verification Checklist

  • Verify the actual closing date and confirmation of gross proceeds received.
  • Confirm the effective date of the registration statement for the resale of Warrant Shares.
  • Review the impact of the new share issuance and warrant exercises on fully diluted share count.
  • Monitor the Company's cash position post-closing to assess working capital sufficiency.
  • Check for any subsequent filings regarding the use of proceeds or changes in the offering terms.